awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26741082-94BD8967-B372-4E01-AE1A-72AD4AE30DE3
Q26741082-94BD8967-B372-4E01-AE1A-72AD4AE30DE3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26741082-94BD8967-B372-4E01-AE1A-72AD4AE30DE3
Cardiovascular safety of anti-diabetic drugs
P2860
Q26741082-94BD8967-B372-4E01-AE1A-72AD4AE30DE3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26741082-94BD8967-B372-4E01-AE1A-72AD4AE30DE3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c1aa8caa82c0d551d22c4c9694dde701cc0f19c5
P2860
Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial.